2 results
Approved WMOWill not start
The primary objective of this study is to further evaluate the safety and tolerability of pegaptanib sodium in subjects with DME.
Approved WMOCompleted
The study aims to limit the use of anthracyclines and to reduce the dose of ATRA. Another aim is to stratify treatment by risk group: standard risk - WBC <10 x 109/l : high risk - WBC >=10 x 109/l. Furthermore this study aims to…